FDA Inspection 1317052 - Solaris Pharma Corp - April 21, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Solaris Pharma Corp, with an inspection on April 21, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Solaris Pharma Corp
Inspection Date: April 21, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · b9f7b248-5c1f-4449-87fb-53f958ce2070